Top Suppliers:I want be here

129186-29-4

129186-29-4 structure
129186-29-4 structure
  • Name: Gidazepam
  • Chemical Name: 2-(7-bromo-2-oxo-5-phenyl-3H-1,4-benzodiazepin-1-yl)acetohydrazide
  • CAS Number: 129186-29-4
  • Molecular Formula: C17H15BrN4O2
  • Molecular Weight: 387.23100
  • Catalog: Signaling Pathways Membrane Transporter/Ion Channel GABA Receptor
  • Create Date: 2016-12-27 07:26:28
  • Modify Date: 2024-01-11 19:20:17
  • Gidazepam is an agonist of GABA receptor channels (GABA RCs).

Name 2-(7-bromo-2-oxo-5-phenyl-3H-1,4-benzodiazepin-1-yl)acetohydrazide
Synonyms (1-Hydrazinocarbonyl)-7-bromo-5-phenyl-1,2-dihydro-3H-1,4-benzodiazepine-2-one
UNII-XMJ87I93Y9
1H-1,4-Benzodiazepine-1-aceticacid,7-bromo-2,3-dihydro-2-oxo-5-phenyl-,hydrazide
gidazepam
Description Gidazepam is an agonist of GABA receptor channels (GABA RCs).
Related Catalog
Target

GABA receptor[1]

In Vitro Gidazepam demonstrates considerably lower affinities to GABA RCs than phenazepam, 3-hydrozyphenazepam, and Br-nordiazepam. This is manifested in different values of the inhibition constant (Ki) of binding of a specific ligand of benzodiazepine receptors, diazepam. For Gidazepam, the Ki value is 2,200±50 nM[1].
In Vivo Mice are distributed into 10 groups of five animals each, treated orally with Gidazepam (GDZ, 1 mg/kg); ester 1 (175 mg/kg); ester 2 (20 mg/kg); esters 3 and 4 (200 mg/kg); mixtures of Gidazepam and esters 1-4. All esters of GABA with monoterpenes display antiseizure effects in 3 h after oral administration as evidenced by increasing of inducing clonic-tonic convulsions (DCTC) and tonic extension (DTE) values. Gidazepam (1 mg/kg) is found to protect against seizures with DCTC and DTE values of 250% and 215%, accordingly; whereas co-administration of Gidazepam and esters 5-7 is shown to increase anticonvulsant activity compared with each compound alone[1].
Animal Admin Mice[1] The outbreed male white mice (18-22 g) are used. Mice are distributed into 10 groups of five animals each, treated orally with Gidazepam 1 mg/kg (GDZ); GABA ester of menthol 175 mg/kg (1); GABA ester of thymol 20 mg/kg (2); GABA ester of carvacrol 200 mg/kg (3); GABA ester of guaiacol 200 mg/kg (4); mixture of Gidazepam and 1; mixture of Gidazepam and 2; mixture of Gidazepam and 3; mixture of Gidazepam and 4. Doses of esters 1-4 are calculated in equimolar amounts with respect to monoterpenes based on our preliminary investigation and from literature citations. The anticonvulsant activity of compounds 1-4 and Gidazepam as well as mixtures of Gidazepam with 1-4 is evaluated in model of acute generalized seizures; pharmacological effect of compounds is estimated in 3 h[1].
References

[1]. N. Ya Golovenko, et al. Pharmacodynamical and Neuroreceptor Analysis of the Permeability of the Blood-Brain Barrier for Derivatives of 1,4-Benzodiazepine. Neurophysiology, Vol. 46, No. 3, June, 2014.

[2]. Nesterkina M, et al. Synthesis and Pharmacological Properties of Novel Esters Based on Monocyclic Terpenes and GABA. Pharmaceuticals (Basel). 2016 Jun 13;9(2). pii: E32.

Density 1.58g/cm3
Boiling Point 675.6ºC at 760mmHg
Molecular Formula C17H15BrN4O2
Molecular Weight 387.23100
Flash Point 362.4ºC
Exact Mass 386.03800
PSA 91.28000
LogP 2.66420
Vapour Pressure 4.14E-18mmHg at 25°C
Index of Refraction 1.698
Storage condition 2-8℃